Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Norbert Meidenbauer"'
Autor:
Alexander Willner, Abbas Agaimy, Katja Fechner, Oliver Ott, Axel Denz, Thomas Weissmann, Norbert Meidenbauer, Daniel Höfler, Udo Gaipl, Benjamin Frey, Manfred Schmidt, Florian Haller, Raymund Horch, Arndt Hartmann, Robert Grützmann, Rainer Fietkau, Sabine Semrau
Publikováno v:
International Journal of Hyperthermia, Vol 40, Iss 1 (2023)
AbstractIntroduction Neoadjuvant chemotherapy and radiotherapy for the management of soft tissue sarcomas (STS) are still preferably delivered sequentially, with or without concurrent hyperthermia. Concurrent delivery of chemo-, radio- and thermother
Externí odkaz:
https://doaj.org/article/f8d1898c64a34e48b5963394f2fafc29
Autor:
Anja Lux, Michaela Seeling, Anne Baerenwaldt, Birgit Lehmann, Inessa Schwab, Roland Repp, Norbert Meidenbauer, Andreas Mackensen, Arndt Hartmann, Gordon Heidkamp, Diana Dudziak, Falk Nimmerjahn
Publikováno v:
Cell Reports, Vol 7, Iss 1, Pp 236-248 (2014)
Genetic differences between humans and in vivo model systems, including mice and nonhuman primates, make it difficult to predict the efficacy of immunoglobulin G (IgG) activity in humans and understand the molecular and cellular mechanisms underlying
Externí odkaz:
https://doaj.org/article/36dfe42316c14b8aa11600d77db51bfd
Autor:
Abbas Agaimy, Valeska Brueckl, Daniela Schmidt, Stephanie Krieg, Evelyn Ullrich, Norbert Meidenbauer
Publikováno v:
Case Reports in Oncology, Vol 6, Iss 1, Pp 134-142 (2013)
Background: Imatinib mesylate (IM) is the standard treatment for BCR-ABL-positive chronic myelogenous leukemia (CML) and is the first-line adjuvant and palliative treatment for metastatic and inoperable gastrointestinal stromal tumor (GIST). IM is no
Externí odkaz:
https://doaj.org/article/3716c52f9bfa4e4097886d2585479ba7
Autor:
Heiner Zimmermann, Christian Koenecke, Martin H. Dreyling, Christiane Pott, Ulrich Dührsen, Dennis Hahn, Norbert Meidenbauer, Ingeborg A. Hauser, Mathias J. Rummel, Dominik Wolf, Michael Heuser, Christian Schmidt, Peter Schlattmann, Matthias Ritgen, Reiner Siebert, Ilske Oschlies, Ioannis Anagnostopoulos, Ralf U. Trappe
Publikováno v:
Leukemia. 36:2468-2478
The prospective multicentre Phase II PTLD-2 trial (NCT02042391) tested modified risk-stratification in adult SOT recipients with CD20-positive PTLD based on principles established in the PTLD-1 trials: sequential treatment and risk-stratification. Af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dadc4d3b2276cb6726230c29b16ae2e7
https://doi.org/10.1038/s41375-022-01667-1
https://doi.org/10.1038/s41375-022-01667-1
Autor:
Torsten Kuwert, Norbert Meidenbauer, Konstantinos Mantsopoulos, Heinrich Iro, Marianne Pavel, Matti Sievert, Sarina K. Mueller, Rainer Fietkau
Publikováno v:
Laryngo-Rhino-Otologie. 101:298-303
ZusammenfassungTraditionell besteht das multimodale Therapiekonzept bei den differenzierten Schilddrüsenkarzinomen in der Thyreoidektomie mit Neck-Dissection (bei cN+-Halsstatus) und adjuvanten Radiojodablation mit abschließender risikoadaptierter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330a4753163e3b178da97e70c223335b
https://doi.org/10.1055/a-1580-7327
https://doi.org/10.1055/a-1580-7327
Autor:
Katja Schlichtig, Lisa Cuba, Pauline Dürr, Laura Bellut, Norbert Meidenbauer, Frank Kunath, Peter J. Goebell, Andreas Mackensen, Frank Dörje, Martin F. Fromm, Bernd Wullich
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 15; Pages: 4558
Oral antitumor therapeutics (OAT) bear a high risk for medication errors, e.g., due to drug–drug or drug–food interactions or incorrect drug intake. Advanced age, organ insufficiencies, and polymedication are putting uro-oncological patients at a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd7d69fb2e89082edebeb9d015eddc5
Autor:
Florian Lüke, Florian Haller, Kirsten Utpatel, Markus Krebs, Norbert Meidenbauer, Alexander Scheiter, Silvia Spoerl, Daniel Heudobler, Daniela Sparrer, Ulrich Kaiser, Felix Keil, Christoph Schubart, Lars Tögel, Sabine Einhell, Wolfgang Dietmaier, Ralf Huss, Sebastian Dintner, Sebastian Sommer, Frank Jordan, Maria-Elisabeth Goebeler, Michaela Metz, Diana Haake, Mithun Scheytt, Elena Gerhard-Hartmann, Katja Maurus, Stephanie Brändlein, Andreas Rosenwald, Arndt Hartmann, Bruno Märkl, Hermann Einsele, Andreas Mackensen, Wolfgang Herr, Volker Kunzmann, Ralf Bargou, Matthias W. Beckmann, Tobias Pukrop, Martin Trepel, Matthias Evert, Rainer Claus, Alexander Kerscher
Publikováno v:
Cancers; Volume 14; Issue 20; Pages: 5040
Simple Summary In Molecular Tumor Boards (MTBs), clinicians and researchers discuss the biology of tumor samples from individual patients to find suitable therapies. MTBs have therefore become key elements of precision oncology programs. Patients liv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b00da4eec23f4019f179d40f032fb2
https://pubmed.ncbi.nlm.nih.gov/36291825
https://pubmed.ncbi.nlm.nih.gov/36291825
Autor:
Norbert Meidenbauer, Peter Hohenberger, Timo Gaiser, Karen J. Fritchie, Arndt Hartmann, Bernd Kasper, Till Braunschweig, Sanja Schmeck, Jens Jakob, Stefan Wiemann, Philip Ströbel, Matthias Bieg, Caterina Giannini, Eva Wardelmann, Simone Hebele, Naveed Ishaque, Udo Kontny, Horia Sirbu, Abbas Agaimy, Robert Grützmann, Roland Eils, Evgeny A. Moskalev, Matthias Schwarzbach, Florian Haller, Rainer Will
Publikováno v:
The American Journal of Pathology. 191:602-617
Solitary fibrous tumors (SFTs) harbor recurrent NAB2-STAT6 gene fusions, promoting constitutional up-regulation of oncogenic early growth response 1 (EGR1)-dependent gene expression. SFTs with the most common canonical NAB2 exon 4-STAT6 exon 2 fusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b51a8c683b5b9c0d52c160dbd73f64c2
https://doi.org/10.1016/j.ajpath.2020.12.015
https://doi.org/10.1016/j.ajpath.2020.12.015
Autor:
Robert Stoehr, Abbas Agaimy, Sabine Semrau, Arndt Hartmann, Norbert Meidenbauer, Konstantinos Mantsopoulos, Lars Tögel
Publikováno v:
Virchows Archiv
Sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) is an exceedingly rare low-grade thyroid malignancy of unknown histogenesis. NUT carcinoma is another rare, highly aggressive neoplasm with predilection for the midline, defined by recurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb0d3a843e03747e4f458c816c7e35cb
http://europepmc.org/articles/PMC8724182
http://europepmc.org/articles/PMC8724182
Autor:
Lars Tögel, Andreas Mackensen, Florian Haller, Lisa Meintker, Heidi Waibel, Daniela Schmidt, Norbert Meidenbauer, Arndt Hartmann
Publikováno v:
JCO Precision Oncology. :233-238
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2f48f5968e04156dba170d89f0c3fc2
https://doi.org/10.1200/po.19.00377
https://doi.org/10.1200/po.19.00377